BioPacific Partners
Tim McCready serves as a Strategy Advisor at the New Zealand Story Group, focusing on enhancing New Zealand's global reputation. As a contributor for the New Zealand Herald, Tim writes special business reports covering international business, trade, and sustainable finance. With extensive experience as a Venture Partner and Principal Consultant at BioPacific Partners, Tim collaborates with multinationals, local firms, and government on strategic projects in food, health, and agriculture. Additionally, Tim acts as Convenor of Judges for the 2degrees Auckland Business Awards and has moderated numerous high-profile business events globally. Previous roles include content producer for the APEC CEO Summit and business development manager at Kahne Animal Health. Tim's educational background includes a Master of Bioscience Enterprise from The University of Auckland and courses in Māori language.
This person is not in the org chart
This person is not in any teams
BioPacific Partners
BioPacific Partners acts as an extension of our client's teams to provide unequalled insights and networks. We are a privately owned business comprising an elite group of high-profile, highly connected individuals underpinned by a very competent analytical workforce. BioPacific Partners works to assist global companies connect with local innovators in Australasia. Our global partners gain great value from our searching and evaluation intelligence – we act as eyes & ears in our region to identify relevant opportunities worth examining. We work with partners to access innovation relevant to their wants and needs - from universities and research institutes through to startup and mature companies and technologies. We offer the most complete and informed coverage of opportunities across Australia and New Zealand in the areas of Pharmaceuticals; Consumer Health; Food Ingredients, Flavours & Fragrances; Healthy Foods and Beverages; Animal Health; Agbio/Agritech. Our team works from initial engagement with local innovators through to deal completion. This includes collaboration, licensing, material supply, equity investment, and acquisition. We also assist with strategy and projects customised to our client's wants, across the life sciences industry.